Vericel Corp’s filing revealed that its Chief Medical Officer Hopper Jonathan Mark unloaded Company’s shares for reported $0.4 million on Jun 02 ’25. In the deal valued at $40.09 per share,10,000 shares were sold. As a result of this transaction, Hopper Jonathan Mark now holds 66,237 shares worth roughly $2.75 million.
Then, Hopper Jonathan Mark bought 10,000 shares, generating $411,300 in total proceeds.
Before that, GILMAN STEVEN C bought 13,125 shares. Vericel Corp shares valued at $551,250 were divested by the Former Director at a price of $42.00 per share.
Canaccord Genuity initiated its Vericel Corp [VCEL] rating to a Buy in a research note published on August 09, 2024; the price target was $57. A number of analysts have revised their coverage, including TD Cowen’s analysts, who began to cover the stock in mid June with a ‘”a Buy”‘ rating. Truist also remained covering VCEL and has increased its forecast on January 25, 2024 with a “Buy” recommendation from previously “Hold” rating. BTIG Research revised its rating on August 08, 2023. It rated VCEL as “a Buy” which previously was an “a Neutral”.
Price Performance Review of VCEL
On Tuesday, Vericel Corp [NASDAQ:VCEL] saw its stock fall -0.22% to $41.50. Over the last five days, the stock has lost -9.19%. Vericel Corp shares have fallen nearly -24.42% since the year began. Nevertheless, the stocks have fallen -4.27% over the past one year. While a 52-week high of $63.00 was reached on 02/05/25, a 52-week low of $37.39 was recorded on 05/01/25.
Levels Of Support And Resistance For VCEL Stock
The 24-hour chart illustrates a support level at 41.03, which if violated will result in even more drops to 40.57. On the upside, there is a resistance level at 41.90. A further resistance level may holdings at 42.31.
